Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon McMahon

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|June 10, 2025
TNFα impairs platelet function by inhibiting autophagy and disrupting metabolism via Syntaxin-17 downregulationGuadalupe Rojas-Sanchez, Jorge Calzada-Martinez, Brandon McMahon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Myeloid growth factorsJeffrey Crawford, James Armitage, Lodovico Balducci, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJason Gotlib, Aaron T Gerds, Prithviraj Bose, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2021
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMichael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018Ruben A Mesa, Catriona Jamieson, Ravi Bhatia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2023
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with MyelofibrosisTamara K Moyo, Ashwin Kishtagari, Matthew T Villaume, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|June 10, 2025
TNFα impairs platelet function by inhibiting autophagy and disrupting metabolism via Syntaxin-17 downregulationGuadalupe Rojas-Sanchez, Jorge Calzada-Martinez, Brandon McMahon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Myeloid growth factorsJeffrey Crawford, James Armitage, Lodovico Balducci, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJason Gotlib, Aaron T Gerds, Prithviraj Bose, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2021
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMichael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018Ruben A Mesa, Catriona Jamieson, Ravi Bhatia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2023
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with MyelofibrosisTamara K Moyo, Ashwin Kishtagari, Matthew T Villaume, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018Michael B Streiff, Bjorn Holmstrom, Dana Angelini, et al.
Pageof 4